NCT00164320

Brief Summary

The purpose of this study is to determine if the TEAM prevention intervention delivered by a physician and an HIV-positive counselor is effective. It is hypothesized that those who receive the intervention will report a higher reduction in risky sex than those who were in the standard-care condition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for phase_2 hiv

Timeline
Completed

Started May 2004

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2004

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

September 9, 2005

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 14, 2005

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2006

Completed
Last Updated

September 14, 2005

Status Verified

September 1, 2005

First QC Date

September 9, 2005

Last Update Submit

September 9, 2005

Conditions

HIV

Outcome Measures

Primary Outcomes (1)

  • Self-reported unprotected (without condoms)anal or vaginal sex with HIV-negative or unknown-status persons.

Interventions

TEAMBEHAVIORAL

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \) 18 years or older, 2) HIV-infected, 3) Sexually active, 3)Receiving HIV primary care at participating clinic, 4) Can communicate in English or Spanish, 5) No previous enrollment in the TEAM study or intervention.

You may not qualify if:

  • \) Participation in a similar study run by the TEAM PI.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Miami School of Medicine

Miami, Florida, 33136, United States

Location

Study Officials

  • Dogan Eroglu, PhD.

    Centers for Disease Control and Prevention

    STUDY DIRECTOR

  • Lisa Metsch, PhD.

    University of Miami

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
FACTORIAL
Sponsor Type
FED

Study Record Dates

First Submitted

September 9, 2005

First Posted

September 14, 2005

Study Start

May 1, 2004

Study Completion

May 1, 2006

Last Updated

September 14, 2005

Record last verified: 2005-09

Locations

US(1)